Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Comput Aided Drug Des ; 15(3): 252-258, 2019.
Article in English | MEDLINE | ID: mdl-30569873

ABSTRACT

BACKGROUND: Acquired immunodeficiency Syndrome (AIDS) is caused by Human immunodeficiency virus type 1 (HIV-1). Pyrazine and Thiazolidinone pharmacophore has diverse biological activities including anti HIV activity. AIMS AND OBJECTIVES: To study binding behavior of Pyrazine- thiazolidinone derivatives on four different crystal structures of HIV- 1RT.These molecules which were already reported as anti-TB were investigated for dual activity as Anti-HIV and Anti-TB. MATERIALS AND METHODS: In the present study we describe a comparative docking study of twentythree derivatives of N-(4-oxo-2 substituted thiazolidin-3-yl) pyrazine-2-carbohydrazide. Binding pattern of these derivatives was gauged by molecular docking studies on four different receptors bearing PDB code 1ZD1, 1RT2, 1FKP and 1FK9 of HIV-RT enzyme using V. Life MDS software Genetic algorithm docking method. RESULT AND DISCUSSION: The studies revealed hydrogen bonds, hydrophobic interaction and pi-pi interactions playing significant role in binding of the molecules to the enzyme. CONCLUSION: Most of the molecules have shown good dock score and binding energy with anti-HIV receptors but Molecules 13 and 14 have potential to act as anti-tubercular and Anti HIV and hence can be further explored for dual activity.


Subject(s)
Anti-HIV Agents/chemistry , Drug Design , Pyrazines/chemistry , Thiazolidines/chemistry , Anti-HIV Agents/pharmacology , Binding Sites , Hydrogen Bonding , Molecular Docking Simulation , Pyrazines/pharmacology , Reverse Transcriptase Inhibitors/chemistry , Reverse Transcriptase Inhibitors/pharmacology , Thiazolidines/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...